Cytiva is a prominent global life sciences leader that specializes in providing technologies, tools, and services to accelerate the development and manufacturing of therapeutics. Operating as an operating company under Danaher Corporation, the brand was formally launched in April 2020 following Danaher’s $21.4 billion acquisition of GE Healthcare Life Sciences.
In 2023, Cytiva significantly expanded its market presence by completing its integration with Pall Life Sciences, solidifying its role as an end-to-end bioprocess partner from therapeutic discovery to final delivery
Showing the single result
